EDGAR Filing Documents for 0001193125-18-161065

Form 8-K - Current report:

SEC Accession No. 0001193125-18-161065

Filing Date

2018-05-11

Accepted

2018-05-11 17:21:55

Documents

Period of Report

2018-05-11

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d582802d8k.htm	8-K	15176
2	EX-99.1	d582802dex991.htm	EX-99.1	34082
3	GRAPHIC	g582802g39u29.jpg	GRAPHIC	5503
	Complete submission text file	0001193125-18-161065.txt		58205

Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306

Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845

Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 18827990
SIC: 2836 Biological Products, (No Diagnostic Substances)